Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)
HKD 11.12
(0.18%)
HKD 11.12
(0.18%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -78.73 Million CNY | 34.61% |
| 2022 | -120.4 Million CNY | 35.28% |
| 2021 | -186.05 Million CNY | -87.02% |
| 2020 | -99.48 Million CNY | -53.61% |
| 2019 | -64.76 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 34.43 Million CNY | 0.0% |
| 2024 Q1 | 34.43 Million CNY | 259.34% |
| 2023 FY | -78.73 Million CNY | 34.61% |
| 2023 Q2 | -17.75 Million CNY | 0.0% |
| 2023 Q4 | -21.61 Million CNY | 0.0% |
| 2023 Q1 | -17.75 Million CNY | 59.67% |
| 2023 Q3 | -21.61 Million CNY | -21.7% |
| 2022 Q2 | -12.75 Million CNY | 0.0% |
| 2022 FY | -120.4 Million CNY | 35.28% |
| 2022 Q3 | -44.02 Million CNY | -245.24% |
| 2022 Q1 | -12.75 Million CNY | 80.38% |
| 2022 Q4 | -44.02 Million CNY | 0.0% |
| 2021 Q3 | -64.98 Million CNY | -86.43% |
| 2021 Q2 | -34.85 Million CNY | 0.0% |
| 2021 FY | -186.05 Million CNY | -87.02% |
| 2021 Q4 | -64.98 Million CNY | 0.0% |
| 2021 Q1 | -34.85 Million CNY | -6.17% |
| 2020 FY | -99.48 Million CNY | -53.61% |
| 2020 Q3 | -32.83 Million CNY | -88.7% |
| 2020 Q1 | -17.4 Million CNY | 0.0% |
| 2020 Q2 | -17.4 Million CNY | 0.0% |
| 2020 Q4 | -32.83 Million CNY | 0.0% |
| 2019 FY | -64.76 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Vincent Medical Holdings Limited | 57.27 Million HKD | 237.467% |